Results 191 to 200 of about 567,668 (313)

Pharmacokinetics and adverse effects of a long‐acting IM dopamine agonist: Cabergoline in healthy horses

Equine Veterinary Education, EarlyView.
Summary Background Pituitary pars intermedia dysfunction (PPID) is commonly treated with pergolide mesylate, a dopamine receptor agonist. Cabergoline is a dopamine receptor agonist that has shown activity on prolactin secretion in horses for up to 10 days.
H. Hess, A. Bracken, S. Rao, Y. Nout‐Lomas, D. Gustafson, L. Bass   +5 more
wiley   +1 more source

Cortico-striatal circuit mechanisms drive the effects of D1 dopamine agonists on memory capacity in mice through cAMP/PKA signalling. [PDF]

Nat Commun
De Risi M, Cavezza D, Torromino G, Capalbo A, Cundin XB, Di Martino R, Alvino FG, Iemolo A, Speranza L, Perrone-Capano C, Crispino M, Cirillo C, Luini A, Sacco F, Grumati P, De Leonibus E.   +15 more
europepmc   +1 more source

Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study. [PDF]

J Endocrinol Invest, 2021
Beccuti G, Guaraldi F, Natta G, Cambria V, Prencipe N, Cicolin A, Montanaro E, Lopiano L, Ghigo E, Zibetti M, Grottoli S.   +10 more
europepmc   +1 more source

Dopamine Agonists and the Suppression of Impulsive Motor Actions in Parkinson Disease

Journal of Cognitive Neuroscience, 2012
S. Wylie, D. Claassen, H. Huizenga, K. Schewel, K. Ridderinkhof, T. R. Bashore, W. P. van den Wildenberg   +6 more
semanticscholar   +1 more source

Alpha‐2‐adrenoreceptor agonists as analgesic drugs in equine medicine

Equine Veterinary Education, EarlyView.
Summary Managing pain in horses is challenging despite the availability of nonsteroidal anti‐inflammatory drugs, local anaesthetics, opioids and α2‐adrenoreceptor agonists. While α2‐agonists are widely used for sedation and restraint, their analgesic properties remain underutilised.
J. A. E. Hubbell, J. Brandly, W. W. Muir III, J. Page, K. Hopster   +4 more
wiley   +1 more source

Studying the suitability of hybrid micelle liquid chromatography for estimating the lipophilicity of some partial dopamine agonists used to attain the reward circuit. [PDF]

R Soc Open Sci, 2021
Wahba MEK, El Wasseef D, El Sherbiny D.
europepmc   +1 more source

Memantine agonist action at dopamine D2^High receptors [PDF]

, 2007
Philip Seeman, Carla Caruso, Mercedes Lasaga   +2 more
openalex   +1 more source

STUDIES ON COGNITIVE AND NEUROPHARMACOLOGICAL CHANGES IN ANIMAL MODEL BY DOPAMINE (D2/D3) AGONIST AND 5HT3 ANTAGONIST

, 2023
Meh jabeen, Muhammad Arfat, Faiza Anis
openalex   +1 more source

Resistance to dopamine agonists in prolactinoma is correlated with reduction of dopamine D2 receptor long isoform mRNA levels.

European Journal of Endocrinology, 2012
Satoko Shimazu, A. Shimatsu, S. Yamada, N. Inoshita, Yuko Nagamura, T. Usui, T. Tsukada   +6 more
semanticscholar   +1 more source

D1/D5 receptor activation promotes long‐term potentiation and synaptic tagging/capture in hippocampal area CA2

The FEBS Journal, EarlyView.
Activation of dopamine receptor D1 (D1R) stimulates PKA and ERK pathways via dissociation of stimulatory and olfactory G protein alpha subunits (Gαs/olf). PKA relieves striatal‐enriched protein tyrosine phosphatase (STEP) inhibition of ERK, promoting cyclic adenosine monophosphate response element‐binding protein (CREB)‐driven transcription of ...
Kevin Chua, Yee Song Chong, Sreedharan Sajikumar   +2 more
wiley   +1 more source